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ABSTRACT
Objective: Women with Turner syndrome (TS) have greater carotid artery intima-media thick-
ness (cIMT) known to be a risk factor for atherosclerosis in adults. To determine whether there
are risk factors for atherosclerosis in children with TS, we compared cIMT, anthropometric and
metabolic parameters between children with TS and healthy controls.
Methods: Data of children with TS with XO karyotype (n=24, mean age: 11.6±3.6) were com-
pared with those of healthy children (n=24, mean age: 10.5±3.6) with respect to anthropomet-
ric parameters, lipid levels, insulin resistance and cIMT which was measured by high resolution
B-mode ultrasonography.
Results: Mean age and cIMT values were similar in the two groups of children. However in chil-
dren with TS, fasting glucose (p=0.01), total cholesterol (p=0.006), triglyceride (p=0.04) levels
and HDL-cholesterol (p=0.002) levels were higher than those of controls. In the TS group, cIMT
correlated positively with LDL-cholesterol (r=0.435, p=0.034) and with systolic blood pressure
(r=0.430, p=0.036) and negatively with HDL-cholesterol (r=-0.518, p=0.01). In stepwise regres-
sion analysis, HDL-cholesterol emerged as a significant predictor of cIMT (b= -0.518, p=0.01)
contributing to 26.8 % of its variability. 
Conclusion: The systolic blood pressure and dyslipidaemia were shown to be risk factors for ath-
erosclerosis in children with TS.
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INTRODUCTION
Turner syndrome (TS) is associated
with insulin resistance, increased inciden-
ce of type 2 diabetes and hypertension,
which all constitute cardiovascular risk
factors. A survey of morbidity and morta-
lity in patients with TS identified by a
chromosomal defect registry found that
cardiovascular diseases, congenital or ac-
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Increased common carotid artery intima-
media thickness (cIMT) is significantly related to
known cardiovascular risk factors and to caro-
tid plaque, a more advanced atherosclerotic le-
sion.(4) Measuring cIMT with ultrasonography
correlates well with pathological measurements
and is reproducible. Increased cIMT is correla-
ted with cardiovascular risk factors and  the se-
verity of coronary atherosclerosis and predicts
cardiovascular events in population groups.(5,
6) Carotid artery IMT as a marker of early athe-
rosclerosis has been studied using vascular ul-
trasonography in children with familial hyperc-
holesterolemia(7), diabetes(8, 9), hypertensi-
on(10) and childhood obesity.(11, 12) Although
the clinical complications of atherosclerosis
such as coronary artery disease and stroke usu-
ally occur in middle and late ages, autopsy stu-
dies have shown that the atherosclerotic pro-
cess in the vascular wall begins in childhood
and is accelerated in the presence of risk fac-
tors.(13, 14) Clustering of cardiovascular risk
factors is seen in children and adolescents with
the highest degree of insulin resistance, sugges-
ting that adult cardiovascular disease is more li-
kely to develop in these young people.(15, 16)
Increased mortality and morbidity have
been reported in TS, and possibly this is in re-
lation  to an increased frequency of diabetes
and cardiovascular diseases.(3, 17) Type 2 di-
abetes mellitus, insulin resistance, and impai-
red glucose tolerance are also relatively more
frequent findings in TS patients. However, no
study has been conducted to investigate the
relationship between cardiovascular risk fac-
tors such as insulin resistance, glucose intole-
rance, dyslipidaemia, hypertension and cIMT
in children with TS. In the present study, we
investigated the relationships between the
risk factors of atherosclerosis and cIMT and
insulin sensitivity indices based on fasting
samples in children with TS.
MATERIALS AND METHODS
Subjects
The TS group consisted of twenty-four
girls (mean age: 11.6±3.6 years) with newly
diagnosed TS on the basis of karyotype
analysis. These children were recruited from
short children who attended the outpatient
clinic of the Pediatric Endocrinology Unit of
Selcuk University Hospital in Konya, Turkey.
The clinical diagnosis of TS was based on
peripheral leucocyte karyotype analysis and
all subjects included in the study had 45, XO
karyotypes. The other karyotype forms were
excluded. Subjects with thyroid dysfunction
and celiac disease were also excluded from
the study. None of the patients were on any
medication such as growth hormone or es-
trogen therapy.
Control subjects (24 girls; mean age:
10.5±3.6 years) were healthy children who
presented to the hospital for minor illnesses
such as common cold. We collected blood
samples of the control group at the time of
the follow-up examination after resolution of
their minor illnesses. Children were exclu-
ded if they had prior major illness including
type 1 or type 2 diabetes, were on medicati-
ons, or had a condition known to influence
body composition, insulin action, or insulin
secretion (e.g.  glucocorticoid therapy,
hypothyroidism, Cushing’s disease, growth
hormone or estrogen therapy). The study
was approved by the local ethics committee
of the Selcuk University. Signed informed
consent was obtained for each subject over
12 years of age, and informed parental con-
sent was also obtained for all children re-
gardless of age.
Each child underwent a complete physi-
cal examination, including anthropometric
measurements. Height was measured to the
nearest 0.5 cm on a standard height board,
and weight was determined to the nearest
0.1 kg on a standard physician’s beam scale
with the subject dressed only in light under-
wear and no shoes. Waist circumference was
measured at the level of the umbilicus with
the patient standing and breathing normally.
Hip circumference was measured at the le-
vel of the iliac crest. Body mass index (BMI)
was calculated as weight (in kilograms) divi-
ded by height (in meters) squared [weight
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(kg)/height (m)2]. Blood pressure was me-
asured with a standard mercury sphygmo-
manometer after the subject had rested for at
least 10 minutes. 
Biochemical analyses
Blood samples were taken in the mor-
ning between 7:30 and 9:30 A.M. after the
children had fasted overnight. After clot-
ting, the serum was separated and bioche-
mical investigations, except for insulin, we-
re performed immediately. A serum sample
was deep-frozen for insulin measurement.
Glucose was determined by the glucose
oxidase method. Plasma concentrations of
total cholesterol, high-density lipoprotein-
cholesterol (HDL-cholesterol), low-density
lipoprotein-cholesterol (LDL-cholesterol)
and triglycerides were measured using a ro-
utine enzymatic method with Olympus
2700 Analyzer (Olympus Diagnostica
GmbH, Ireland). Insulin levels were measu-
red by an IMMULITE immunoassay (IMMU-
LITE Diagnostic Products Corporation, Los
Angeles, CA). Sensitivity and specificity of
the insulin kit were 92.86% and 87.01%, res-
pectively. 
Insulin indices derived from fasting
blood samples
The homeostasis model assessment of in-
sulin resistance (HOMA-IR), quantitative insu-
lin-sensitivity check index (QUICK-I) and fas-
ting glucose-to-insulin ratio (FGIR) were deri-
ved as estimates of insulin resistance. FGIR
was calculated as fasting insulin concentrati-
on (µU/mL)/fasting glucose concentration
(mg/dL). HOMA-IR was calculated as fasting
insulin concentration (µU/mL) X fasting glu-
cose concentration (mmol/L)/22.5.(18) QU-
ICK-I was calculated as 1/[(log fasting insulin
concentration (µU/mL) + log fasting glucose
concentration (mg/dL)].(19)
Ultrasound imaging
All patients were examined by a pediat-
ric cardiologist who was blinded to the par-
ticipants’ laboratory values and risk factor
levels. After routine cardiovascular exami-
nation, a chest roentgenogram and electro-
cardiogram were obtained in all patients.
Scans were obtained at rest; the subjects
were laid quietly for 10 minutes before the
first scan. A Philips Sonos 5500 system with
a 7-12 MHz transducer ultrasonic imager
was used for echocardiographic assess-
ments. The measurements were obtained
using the published standards recommen-
ded by the American Society of Echocardi-
ography.(20) The participants were exami-
ned in the supine position with the head
turned slightly to the left. Longitudinal ima-
ges of the common carotid artery were ob-
tained by combined B-mode and color
Doppler ultrasound examinations. The
cIMT of the common carotid artery posteri-
or (far) wall was measured with the electro-
nic calipers of the machines, as described
by Pignoli et al.(21) On a longitudinal, two-
dimensional ultrasound image of the caro-
tid artery, the far wall of the carotid artery
was displayed as two bright white lines se-
parated by a hypoechogenic space. The
distance between the leading edge of the
first bright line of the far wall and the lea-
ding edge of the second bright line indica-
ted the cIMT. The cIMT was measured du-
ring end diastole. The cIMT measurements
were performed on-line. The mean cIMT
was calculated for each child as the avera-
ge of three consecutive measurements of
maximum far wall thickness obtained from
the common carotid artery, 20 mm below
the carotid bulb. The coefficients of variati-
on of the measurements were less than 3%.
Statistical methods
The data were expressed as means±SD.
The Kolmogorov-Smirnov test was applied
separately for groups to check the norma-
lity of the variables. Differences in the me-
ans of variables were tested using both pa-
rametric and non-parametric tests depen-
ding on the distribution of the variables.
Triglyceride, fasting insulin, FGIR and HO-
MA-IR variables (not normally distributed)were log-transformed before data analysis.
Statistical correlation was assessed using
the Pearson test (r). Separate relationships
between cIMT and insulin sensitivity indi-
ces (HOMA-IR, FGIR and QUICK-I) were
also examined after adjustment for age,
sex, BMI, waist/height ratio, waist/hip rati-
o, systolic and diastolic blood pressure, to-
tal cholesterol, triglycerides, LDL-choleste-
rol, HDL-cholesterol using general linear
regression models (backward analysis).
Statistical significance was taken as p<0.05.
All statistical analysis was performed using
the Statistical Package for Social Sciences
(SPSS/Windows version 11·0, SPSS Inc.,
Chicago, IL, USA).
RESULTS
The characteristics of the study populati-
on are shown in Table 1. Both the TS group
and control group showed no significant dif-
ferences in terms of age, weight, systolic and
diastolic blood pressure, LDL-cholesterol,
fasting insulin, insulin sensitivity indices and
cIMT. Subjects in the TS group were signifi-
cantly shorter than the controls (125.3±14.7
cm versus 135.9±16.2, p=0.021) and had sig-
nificantly higher BMI (20.0±4.4 versus
16.9±3.0, p=0.007), waist/height (0.5±0.05
versus 0.4±0.02, p=0.001) and waist/hip
(0.9±0.06  versus 0.87±0.05, p=0.04) ratios.
Total cholesterol, HDL-cholesterol and trigl-
Table 1: The clinical and metabolic characteristics of the Turner Syndrome and control groups (mean ±SD values)
Turner Syndrome group Control group
(n= 24) (n= 24) p*
Age (yrs) 11.6±3.6 10.5±3.6 0.288
Weight (kg) 32.8±12.8 32.8±13.6 0.986
Height (cm) 125.3±14.7 135.9±16.2 0.021
Body mass index  (kg/m2) 20.0±4.4 16.9±3.0 0.007
Waist/height ratio 0.50±0.05 0.40±0.02 0.001
Waist/hip ratio 0.90±0.06 0.87±0.05 0.04
Systolic blood pressure (mmHg) 105.8±16.4 99.7±11.0 0.143
Diastolic blood pressure (mmHg) 69.3±14.1 64.3±11.3 0.184
Carotid artery intima media thickness (mm) 0.373±0.060 0.377±0.132 0.901
LIPIDS
Total cholesterol (mg/dL) 181.5±33.6 156.9±25.5 0.006
Triglycerides (mg/dL) 112.5±84.0 73.6±35.1 0.04
LDL-cholesterol (mg/dL) 107.6±30.3 99.1±20.2 0.260
HDL-cholesterol (mg/dL) 53.3±12.4 43.0±9.4 0.002
GLUCOSE HOMEOSTASIS
Fasting glucose (mg/dL) 92.7±7.5 86.7±8.2 0.01
Fasting insulin (µU/mL) 5.7±3.2 5.9±4.6 0.905
FGIR 24.7±19.0 24.7±20.4 0.998
HOMA-IR 1.34±0.78 1.20±0.97 0.796
QUICK-I 0.384±0.05 0.392±0.05 0.604
*p≤0.05 accepted as significant. FGIR: fasting glucose-to-insulin ratio; HOMA-IR: homeostasis model assessment for insulin resistance QUICK-I: quantitative
insulin-sensitivity check index
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yceride levels were significantly elevated in
children with TS, whereas LDL-cholesterol
was only slightly higher than the controls
without being significant. Fasting glucose
was significantly higher in the TS group
(92.7±7.5  versus 86.7±8.2 mg/dL, p=0.01).
However, differences in fasting insulin and
insulin sensitivity indices were non-signifi-
cant between the groups.
There was no significant difference bet-
ween the groups for cIMT (0.373±0.06 versus
0.377±0.132 mm; p=0.901). Table 2 shows
the correlations between cIMT and other
cardiovascular risk factors in children with
TS. When cIMT was considered as a conti-
nuous variable in the whole population of
the TS group, it was found to be significant-
ly positively correlated in univariate analysis
with systolic blood pressure (r=0.430,
p=0.036), LDL-cholesterol (r=0.435, p=0.034)
and FGIR (r=0.376, p=0.07) and significantly
negatively correlated with HDL-cholesterol
(r=–0.518, p=0.01).  
In the control group there was a signifi-
cant relationship between weight (r=0.413,
p=0.045), BMI (r=0.535, p=0.007) and wa-
ist/hip ratio (r=–0.469, p=0.021). There were
no significant relationships between cIMT
and other clinical and laboratory parameters
in this group.
In the regression analysis, HDL-choleste-
rol was negatively correlated with increased
Table 2: Relationships between carotid artery intima media thickness, insulin sensitivity indices and other cardiovascular
risk factors in children with Turner Syndrome and in the control group 
Turner syndrome group Control group
r p* r p*
Age(yrs) 0.25 0.908 0.176 0.410
Weight (kg) -0.011 0.960 0.413 0.045
Height (cm) 0.014 0.949 0.238 0.263
Body mass index  (kg/m2) -0.084 0.695 0.535 0.007
Waist/height ratio -0.261 0.217 0.216 0.311
Waist/hip ratio -0.127 0.554 -0.469 0.021
Systolic blood pressure (mmHg) 0.430 0.036 -0.035 0.872
Diastolic blood pressure (mmHg) 0.236 0.268 0.212 0.320
LIPIDS
Total cholesterol (mg/dL) 0.204 0.339 0.081 0.707
Triglycerides (mg/dL) 0.137 0.524 -0.201 0.347
LDL-cholesterol (mg/dL) 0.435 0.034 0.041 0.849
HDL-cholesterol (mg/dL) -0.518 0.01 0.280 0.186
GLUCOSE HOMEOSTASIS
Fasting glucose (mg/dL) 0.052 0.808 -0.041 0.849
Fasting insulin (µU/mL) -0.260 0.220 -0.026 0.906
FGIR 0.376 0.07 -0.135 0.528
HOMA-IR -0.226 0.288 -0.031 0.884
QUICK-I 0.332 0.113 -0.086 0.688
*p≤0.05 accepted as significant. FGIR: fasting glucose-to-insulin ratio HOMA-IR: homeostasis model assessment for insulin resistance QUICK-I: quantitative
insulin-sensitivity check indexcIMT (b=-0.518, p=0.01, R2=26.8%) even af-
ter adjusting for age, weight, BMI, waist/he-
ight ratio, waist/hip ratio, systolic and dias-
tolic blood pressure, total cholesterol, trigl-
ycerides, LDL-cholesterol, fasting glucose
and insulin, insulin sensitivity indices as co-
factors with the total variance explained be-
ing 26.8%. HOMA-IR, QUICK-I and FGIR
were not significantly correlated with cIMT
after adjusting for atherosclerotic risk factors.
Figure 1 shows the correlation between
HDL-cholesterol and cIMT.
DISCUSSION
High risk factors for atherosclerosis were
defined as obesity, diabetes, hypertension
and dyslipidaemia in adults with TS. Howe-
ver, up to now, there was a lack of unders-
tanding of the risk factors for atherosclerosis
in children with TS. 
Otsberg JE et al(22) demonstrated the wi-
despread structural vascular differences in
adult women with TS characterized by enlar-
gement of conduit arteries and increased ca-
rotid intima thickening, compared with nor-
mal controls. In the present study, we found
no difference between the TS and the con-
trol group in terms of cIMT. However, we
showed that there were several important re-
lationships between cIMT and cardiovascu-
lar risk factors in the TS group.
Coronary heart disease is the most com-
mon cause of death in both women and
men, and adults with TS seem to have seve-
ral risk factors for its early development.(23)
The risk of hypertension is three-fold in TS
patients when compared to the general po-
pulation.(3) The mechanisms leading to
hypertension in these girls are unknown and
not clearly related to the cardiac or renal
congenital abnormalities.(24) Hypertension
has been described with increased frequency
in patients with TS even in the absence of
aortic coarctation and obvious structural re-
nal abnormalities or history of recurrent uri-
nary infections.(25, 26) In addition, in pati-
ents with TS, high levels of triglycerides may
be accompanied by high blood pressure.(23)
In the present study, the TS group had hig-
her blood pressure measurements than the
control group, but the difference was not of
statistical  significance. However, there was a
significant relation between cIMT and systo-
lic blood pressure in the TS group. 
In the present study, we found higher le-
vels of lipids in the TS group compared to
the control group. Garden et al(27) sugges-
ted that hypercholesterolemia occurs in 50%
of women with TS over 21 years of age.(27)
In a group of women with TS who were tes-
ted, hypercholesterolemia was diagnosed in
nearly 37% of females, a frequency  which
was twice as great as in the general popula-
tion.(28) Analysis of large prospective studi-
es revealed that to assess the risk among
women, the HDL-cholesterol level seems to
play an essential role. HDL-cholesterol levels
below 40 mg/dl (<1.0 mmol/l), which is an
indisputable cardiovascular risk factor, were
observed in 25% of the population with TS
and in 5% of the healthy population. This fi-
ve-fold difference confirms the suspicion
that young women with TS are also more
exposed to this cardiovascular risk fac-
tor.(29, 30) Ostberg et al(31) used women
Figure 1: Association between carotid artery intima media
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with premature ovarian failure as controls, in
addition to normal controls, and found an
essentially comparable cholesterol profile,
including triglycerides, to the cholesterol
profile in TS, while normal controls had lo-
wer levels of cholesterol. Van et al(32),
using the same approach with a premature
ovarian failure control group, found an ele-
vated cholesterol profile in TS, with a redu-
ced LDL size, suggesting a more atherogenic
lipid profile.(32) These factors contribute to
the increased patients’ risk of cardiovascular
disease. 
cIMT is affected by many factors inclu-
ding serum lipids. Autopsy studies in chil-
dren have also shown a significant relations-
hip between serum cholesterol concentration
and early atherosclerotic lesions.(33, 34) Ca-
se-control studies of children and young
adults demonstrate that familial hypercholes-
terolemia and borderline hypertension are
associated with greater cIMT.(7, 10) In the
present study, serum lipid levels (total cho-
lesterol and triglycerides) in TS children we-
re significantly higher than those of healthy
subjects. Although HDL-cholesterol level was
slightly but significantly higher in TS children
than in the controls, we found a significant
positive relation between cIMT and LDL-cho-
lesterol and a negative correlation between
cIMT and HDL-cholesterol levels, which
might have implications for future co-morbi-
dities. Multiple linear regression analysis sho-
wed that cIMT had a quantitative relationship
with HDL-cholesterol, suggesting that it may
be a possible risk factor for atherosclerosis.
Although TS girls had higher BMI levels, this
correlation was valid after adjusting for BMI.
There are several abnormalities in gluco-
se metabolism in TS and they include an in-
creased frequency of abnormal glucose tole-
rance, hyperinsulinaemia and reduced insu-
lin sensitivity. Type 2 diabetes mellitus has
been diagnosed two to four times more of-
ten among women with TS than in the gene-
ral population, moreover, it is being detected
at a younger age.(35, 37) Women with TS
have been shown to be insulin resistant
which in itself has been implicated in the
development of coronary artery disea-
se.(35, 38) A large proportion of adoles-
cent and adult TS patients exhibit impai-
red glucose tolerance or overt type 2 di-
abetes during an oral glucose tolerance
test.(39, 40) As in the general population,
excess weight and an abnormal lipid pro-
file, in particular excess triglyceride levels,
worsen insulin sensitivity. In the present
study, we showed that the TS group had
significantly elevated fasting glucose le-
vels; however, there was no difference
between the groups for insulin sensitivity
indices. Previous studies have indicated
that type 2 diabetes mellitus occurs with
increased frequency in TS and this has be-
en shown to affect cardiovascular risk ad-
versely in females.(36, 41) In the present
study, we did not detect glucose intole-
rance in the TS group diagnosed during
childhood. The number of subjects is rela-
tively small which might explain these
non significant results. Disorders of gluco-
se tolerance, type 2 diabetes, dyslipida-
emia, obesity and liver dysfunction often
are delayed until adulthood.(29, 42) In the
present study, we were unable to show a
relationship between fasting glucose-insu-
lin levels and cIMT. These observations
suggest that elevated fasting glucose-insu-
lin levels and insulin sensitivity indices
may not affect cIMT at younger ages. 
Women with TS usually present with in-
creased BMI and waist/hip ratio values.(28)
In the present study BMI levels were signifi-
cantly higher in the TS group than in healthy
children. We did not find a significant relati-
onship between anthropometric data and
cIMT. The reason for this negative result
might be the fact that our subjects had not
very high BMI measurements as in obesity.  
In conclusion, systolic blood pressure
and dyslipidaemia might be associated with
early atherosclerosis in children with TS. On
the basis of these considerations, in childho-
od, a fasting lipid profile should be regularly
checked in the follow-up of TS patients.REFERENCES
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